Wall Street is positive on Cassava Sciences Inc (SAVA). On average, analysts give the stock a Hold rating. The average price target is $63.333, which means analysts expect the stock to gain 291.91% over the next twelve months. This average ranking gives the stock an analyst rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.
Why are analyst ratings important?
A company’s financial statements are an important factor weighted by experts when analyzing a company’s health. Beyond the numbers, analysts follow specific industries closely and are able to understand in detail how a storm in one part of the world can shut down supply chains, causing consumption to change across the globe. This knowledge allows investors to react to potential market changes before they are revealed in a quarterly announcement.
InvestorsObserver averages the ratings of all these analysts and ranks these averages into percentiles. This allows you to compare stocks in more detail than the usual five-level system used by the majority of investors.
What’s going on with Cassava Sciences Inc stock today?
Cassava Sciences Inc (SAVA) stock is down -4.07% while the S&P 500 is up 1% at 10:39 a.m. Friday, July 29. SAVA is down -$0.68 from the previous closing price of $16.84 on volume of 708,763 shares. Over the past year, the S&P 500 is down -6.93% while SAVA is down -84.36%. SAVA has lost -$1.16 per share over the past 12 months. Click here for the full stock report for Cassava Sciences Inc. stock.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.